BR0113668A - Oligoelementos - Google Patents

Oligoelementos

Info

Publication number
BR0113668A
BR0113668A BR0113668-2A BR0113668A BR0113668A BR 0113668 A BR0113668 A BR 0113668A BR 0113668 A BR0113668 A BR 0113668A BR 0113668 A BR0113668 A BR 0113668A
Authority
BR
Brazil
Prior art keywords
edta
trace elements
providing
relates
sodium selenite
Prior art date
Application number
BR0113668-2A
Other languages
English (en)
Other versions
BR0113668A8 (pt
BRPI0113668B1 (pt
Inventor
Robert Naylor Laurie
Lambertus Petrus Vosloo
Original Assignee
Warburton Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warburton Technology Ltd filed Critical Warburton Technology Ltd
Publication of BR0113668A publication Critical patent/BR0113668A/pt
Publication of BRPI0113668B1 publication Critical patent/BRPI0113668B1/pt
Publication of BR0113668A8 publication Critical patent/BR0113668A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/40—Mineral licks, e.g. salt blocks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Compounds Of Iron (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"OLIGOELEMENTOS". A invenção refere-se a um processo de preparação de uma solução de oligoelemento que inclui as etapas de fornecer pelo menos um complexo de EDTA; de fornecer uma solução de selenito de sódio e de combinar o (s) complexo (s) de EDTA e a solução de selenito de sódio. A invenção também refere-se a pelo menos um complexo de EDTA preparado usando-se EDTA dissódico ou ácido EDTA; selênio e qualquer outro mineral adequado.
BRPI0113668A 2000-08-28 2001-08-17 oligoelementos BR0113668A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200004456 2000-08-28
PCT/IB2001/001486 WO2002017933A1 (en) 2000-08-28 2001-08-17 Trace elements

Publications (3)

Publication Number Publication Date
BR0113668A true BR0113668A (pt) 2003-06-03
BRPI0113668B1 BRPI0113668B1 (pt) 2015-08-11
BR0113668A8 BR0113668A8 (pt) 2018-03-06

Family

ID=25588884

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113668A BR0113668A8 (pt) 2000-08-28 2001-08-17 oligoelementos

Country Status (11)

Country Link
US (3) US6638539B2 (pt)
EP (1) EP1339416B1 (pt)
AU (2) AU2001279994B2 (pt)
BR (1) BR0113668A8 (pt)
CA (2) CA2420766C (pt)
DK (1) DK1339416T3 (pt)
ES (1) ES2394080T3 (pt)
MX (1) MXPA03001836A (pt)
NZ (1) NZ524848A (pt)
WO (1) WO2002017933A1 (pt)
ZA (1) ZA200106875B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524848A (en) * 2000-08-28 2004-07-30 Warburton Technology Ltd Trace elements
AU2002351537A1 (en) * 2002-10-31 2004-06-18 Piotr Zajac Feed additive and process for manufacturing thereof
US7285292B2 (en) * 2004-04-29 2007-10-23 Warburton Technology Limited Trace elements
HUE059540T2 (hu) 2004-05-03 2022-11-28 Warburton Technology Ltd Nyomelemek
AU2005281393B2 (en) * 2004-09-09 2012-01-12 Virbac (Australia) Pty Ltd Trace elements
CA3150440C (en) * 2008-12-09 2023-11-07 Warburton Technology Limited Trace element solution for animals
US20110076341A1 (en) * 2009-09-25 2011-03-31 William Alfred Smith Trace elements
ES2742812T3 (es) 2012-05-14 2020-02-17 Warburton Technology Ltd Solución de oligoelementos
WO2017060757A1 (en) 2015-10-09 2017-04-13 Warburton Technology Limited Trace element solution
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
CA3089032A1 (en) 2018-01-19 2019-07-25 Compass Minerals Usa Inc. Multi-source micronutrient composition and methods of treating soil with the same
AU2020312430B9 (en) * 2019-07-12 2022-02-17 Chemvet Australia Pty Ltd Injectable nutritional supplement

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335116A (en) 1980-10-07 1982-06-15 University Patents, Inc. Mineral-containing therapeutic compositions
HU187467B (en) 1981-11-02 1986-01-28 Vetoemagtermeltetoe Es Ertekesitoe Vallalat,Hu Method for producing preparation suitable for preventing health deterioration of alimentary origin promoting the utilization of fodder of animals
HUT58194A (en) * 1990-08-29 1992-02-28 Nyirseg Konzervipari Vallalat Method for producing foodstuff-preparations suitable for introducing biologically important micro- and macro-elements
DE19617185A1 (de) * 1996-04-29 1997-10-30 Muehle Ebert Dielheim Gmbh Futtermittel oder Arzneimittel zur Verbesserung des Gesundheitszustandes und/oder Prävention oder Behandlung von ekzematischen Erkrankungen von Pferden
NZ524848A (en) * 2000-08-28 2004-07-30 Warburton Technology Ltd Trace elements
US20030021836A1 (en) * 2001-04-20 2003-01-30 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
US7670688B2 (en) * 2001-06-25 2010-03-02 Applied Materials, Inc. Erosion-resistant components for plasma process chambers
US7285292B2 (en) * 2004-04-29 2007-10-23 Warburton Technology Limited Trace elements

Also Published As

Publication number Publication date
USRE41390E1 (en) 2010-06-22
US6638539B2 (en) 2003-10-28
ZA200106875B (en) 2001-09-05
CA2589059A1 (en) 2002-03-07
US20020068079A1 (en) 2002-06-06
US20040235945A1 (en) 2004-11-25
MXPA03001836A (es) 2004-03-26
AU7999401A (en) 2002-03-13
WO2002017933A1 (en) 2002-03-07
EP1339416B1 (en) 2012-11-07
US8231910B2 (en) 2012-07-31
EP1339416A1 (en) 2003-09-03
CA2420766A1 (en) 2002-03-07
CA2589059C (en) 2011-10-04
ES2394080T3 (es) 2013-01-17
EP1339416A4 (en) 2004-02-04
BR0113668A8 (pt) 2018-03-06
BRPI0113668B1 (pt) 2015-08-11
AU2001279994B2 (en) 2004-09-02
DK1339416T3 (da) 2013-02-18
NZ524848A (en) 2004-07-30
CA2420766C (en) 2007-12-11

Similar Documents

Publication Publication Date Title
BR0010242A (pt) Composições quìmicas que atraem artrópodes
BR0113668A8 (pt) oligoelementos
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
BR0007472A (pt) Agente contendo paramilonas, seco por congelação, sua produção e utilização
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
TR200202806T2 (tr) 4-Triflorometilsulfinilpirazol türevi hazırlama süreci
ES2164785T3 (es) Composiciones orales que contienen compuestos estannosos estabilizados.
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
HUP0304083A2 (hu) Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására
BR0115188A (pt) Processo para a preparação de antitrombina iii latente
BR0211586A (pt) Barra de sabão transparente e método de fabricação da mesma
HRP20050270A2 (en) Substituierte heterocyclylpyrimidine
ATE224385T1 (de) Kristallmodifikation der liponsäure
ES2152494T3 (es) Composiciones pigmentarias.
DK0865271T4 (da) Anvendelse af 2-ethylhexyl alfa-cyano-beta, beta-diphenylacrylat med henblik på at forbedre stabiliteten over for lys af p-methylbenzyliden-kamfer
BRPI0418746A (pt) produto e processo de indústria de laticìnios
DE50115757D1 (de) Nasensalbe auf basis von vaselin
GB9706223D0 (en) Chemical compositions
AR004476A1 (es) Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas
BR9804638A (pt) Processo para reduzir o comprimento de cadeia de sulfano de bis-(sililorganil)-polissulfanos.
YU74401A (sh) Postupak za dobijanje 2s-3-amino-3-arilpropionske kiseline i njenih derivata
BR9909756A (pt) Processo para a preparação de um composto
MX172229B (es) Metodos para la fabricacion de derivados de la progesterona

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. A23K 1/175, A61K 33/04, A61K 33/30

Ipc: A61K 33/04 (2006.01), A61K 33/30 (2006.01), A61K 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2015, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/28 (2006.01), A23K 10/40 (2016.01), A23K 2